About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming the treatment landscape for central nervous system (CNS) disorders. Our commitment to innovation drives us to identify and address critical care gaps, resulting in the development of unique products that leverage novel mechanisms of action to significantly improve patient outcomes. Our award-winning neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine relief. We are also advancing multiple late-stage development programs aimed at tackling a diverse array of serious neurological and psychiatric conditions affecting over 150 million individuals in the United States. Together, we are dedicated to solving some of the most pressing challenges related to brain health, allowing patients and their families to thrive. Discover more about our mission and advancements at www.axsome.com.

